Eye irritation due to lack of tear or poor quality, known as "dry eye syndrome" has become a growing concern of our time. It is estimated that 37% of the population is affected, a value that reaches 45% of women aged forty and reaches 70% in the group of women over sixty. The WHO predicts that environmental conditions, stress, drug abuse and poor eating habits make these percentages will increase their reach in today's society.
This new phenomenon is to challenge the dryness of the ocular surface by early tear film break, mainly due to the alteration of the Meibomian glands, a sebaceous glands inside the eyelids. The diagnosis is complex, certainly. Each person requires an accurate and thorough analysis, which provide tailored and more effective therapeutic strategy. Thus, one must analyze the lifestyle, stress and food and, of course, perform a scan of the eye surface that determine the state of sensory nerves (responsible for pain), the stability of the tear and fundamentally Meibomian glands.
As the director of Advanced Ophthalmic area, Dr. Carlos Verges: "The good news is that today, we have new treatments that can help solve the problems of these patients. We have new anti-inflammatory drugs and can enhance the biological condition of the tissue by applying drops with growth factors or stem cells obtained from blood plasma or ocular surface thereof ". However, the big news, highlights Dr. Verges, is the possibility of applying laser, high frequency pulsed light IPL. This technique, painless and does not require surgery, "shows very good results, with a very high efficiency, which makes us think that many people with dry eye may benefit from this new treatment."
The high frequency IPL laser activates the circulation of the eyelids and the metabolism of the Meibomian glands. It is precisely the Meibomian glands that produce fat and other components which lubricate and nourish the eye surface, stabilizing the tear film to prevent breakage and drying on contact with air.